Dr. Donevan Westerveld, MD

Dr. Westerveld practices at Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida.

Dr. Westerveld's NPI, 1588027239, was assigned on March 31, 2016. Dr. Westerveld graduated from University Of Florida College Of Medicine in 2016. Dr. Westerveld holds Florida license ME139367.

Dr. Westerveld's primary practice is Jacksonville Center for Endoscopy - Southside, at 4800 Belfort Rd, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 265-4801.

Dr. Westerveld's primary practice is Jacksonville Center for Endoscopy - Southside in Jacksonville, Florida. Dr. Westerveld is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Borland Groover. Dmand AI also links Dr. Westerveld to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Westerveld practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Westerveld's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Westerveld is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Westerveld's licenses on file in 8 states: Florida, Michigan, Indiana, Missouri, New York, Texas, Wisconsin and Minnesota.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Westerveld treats.

CMS data shows 1,032 Medicare services from Dr. Westerveld across 14 procedure codes in 2024, for 429 Medicare patients. Medicare paid $97,909 for them.

CMS counts 429 Medicare patients who saw Dr. Westerveld in 2024. The largest group is 75 to 84, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Westerveld's median patient age at 60, with 57% women.

In 2024, Dr. Westerveld wrote 459 Medicare Part D claims for 234 patients. 86% of them were for generic drugs. CMS names the drug for 311 of them, across 7 drugs with 11 or more claims each, at $9,234 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Westerveld for performance year 2024, reported as part of a group. Dr. Westerveld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Westerveld as offering telehealth. CMS counts 175 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Westerveld, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 47 papers to Dr. Westerveld, published from 2013 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Colonoscopy, Weight Loss and Colonic Polyps. Dr. Westerveld has published most often in Endosc Int Open. Dr. Westerveld's most frequent co-authors are Reem Z. Sharaiha, MD, MS, Dennis J. Yang, MD and Peter V. Draganov, MD.

CMS Open Payments shows 234 general payments to Dr. Westerveld from 31 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 87% of the total. Abbvie Inc. paid the most, $733.

Dr. Westerveld graduated from University Of Florida College Of Medicine in 2016.

Dr. Westerveld is in network with 20 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.